Synaptogenix (NASDAQ:SNPX) Stock, Quote.Headers.trade-ideas

Synaptogenix

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

influencer-4081842

News

SNPX

Synaptogenix shares are trading lower Thursday morning. The company announced a 1-for-25 reverse stock split.

What&#39;s Going On With Synaptogenix (SNPX) Stock?

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACVA

AGRX

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

ATNI

BBLG

BELFA

BZFD

DOCN

DPRO

EAST

ETSY

EZFL

GBNH

GSHD

INDV

KTOS

LCID

LNTH

LRHC

LUNG

MATV

MGPI

MNPR

MNTS

NOVA

NVAX

NVDA

OCUL

QTWO

RELY

RILY

RIVN

ROOT

RXRX

SMCI

SNPS

TRUE

VERO

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Pre-Market Outlook

BELFB

EFOI

ELAB

ALPS ETF Trusthen & Steers Global Realty Majors ETF

Shares of  NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.

Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Synaptogenix Inc

SNP SCHNEIDER NEUREITHER by SNP Schneider Neureither & Partner AG

SNP Schneider-Neureither & Partner SE

Buybacks

AerCap Holdings Plans New $500M Share Repurchase Program, Which Will Run Through March 31, 2025

Piper Sandler analyst Adam Maeder initiates coverage on Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) with a Overweight rating and announces Price Target of $131.

Price Target

Initiation

Analyst Ratings

Piper Sandler Initiates Coverage On Abbott Laboratories with Overweight Rating, Announces Price Target of $131

Working together with NVIDIA, SLB will build and optimize models to the specific needs and requirements of the data-intensive energy industry, including subsurface exploration, production operations and data management.&nbsp;

SLB, NVIDIA Partner To Develop Generative AI Solutions For The Energy Industry

Chinese EV maker Nio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) is reportedly eyeing taking over Volkswagen brand Audi&#8216;s car plant in Vorst, a city in Brussels.
What Happened: A Nio delegation visited the Vorst plant in recent weeks and is working on a bid to submit to Audi parent Volkswagen by next Monday, <a href="https://www.tijd.be/ondernemen/auto/chinees-nio-kandidaat-overnemer-voor-audi-brussels-fabriek/10565046.html">reported</a> Belgian newspaper De Tijd. Belgium-based D&#8217;Ieteren is also interested in the plant, the report said.
Volkswagen has decided not to make any more vehicles at the plant after the last Q8 e-tron SUV rolls off the production line next year. Unless the German automaker finds a buyer, the plant will be closed, leaving 2,910 employees unemployed, the report said. 
Why It Matters: For Nio, having a plant in Europe will help it avoid the high tariffs being considered for EV imports from China. 
The European Commission is <a href="https://www.benzinga.com/news/24/09/40810974/us-ally-urges-eu-to-reconsider-tariffs-on-chinese-evs-we-dont-need-another-war">expected to propose </a>final tariffs of up to 35.3% on electric vehicles manufactured in China, in addition to the standard 10% car import duty applied by the EU.&nbsp;
The Chinese EV maker started<a href="https://www.benzinga.com/markets/equities/24/09/40925180/teslas-chinese-competitor-nio-begins-deliveries-of-new-es8-in-europe-amid-eu-tariff-concerns-rep"> delivering the ES8 SUV </a>to customers in Europe earlier this month. The vehicle is referred to as the EL8 in the geography due to an older lawsuit with Audi. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40933228/tesla-registrations-in-eu-take-a-hit-in-2024-as-ev-demand-slows-volkswagen-volvo-and-toyota-continue">Tesla Registrations In EU Take A Hit In 2024 As EV Demand Slows: Volkswagen, Volvo, And Toyota Continue To Gain Speed</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

Media

Chinese EV Maker Nio Eyes Audi's Brussels Plant Amid European Expansion: Report

UBER

Darden Restaurants Inks Pact With Uber To Introduce On-Demand Delivery, with Olive Garden The First To Pilot

General

GOEV

Canoo Announced That The U.S. Customs And Border Protection Has Officially Approved Final Activation Of Canoo's Oklahoma City Operations As A Foreign-Trade Zone, Becoming One Of The Largest FTZs In The State Of Oklahoma

Bernstein analyst Aneesha Sherman maintains Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Outperform and lowers the price target from $112 to $109.

Bernstein Maintains Outperform on Nike, Lowers Price Target to $109

Management

BLDR

Builders FirstSource Names Pete Beckmann To Succeed Peter Jackson As CFO

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Gran Tierra Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTE#NYSE">GTE</a>)</h3>
<ul>
<li>On Sept. 18, Gran Tierra Energy announced the closing of an additional $150 million aggregate principal amount of its 9.500% senior secured amortizing notes due 2029. The company's stock fell around 31% over the past month and has a <a href="https://www.benzinga.com/quote/GTE">52-week low of $4.72</a>.</li>
<li>RSI Value: 27.50</li>
<li>GTE Price Action: Shares of Gran Tierra Energy fell 6.4% to close at $5.90 on Wednesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">latest GTE new</a>s. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="846" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070435/image-149.png" alt="" class="wp-image-555845" style="width:682px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070435/image-149.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070435/image-149-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070435/image-149-768x716.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Vivakor inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIVK#NASDAQ">VIVK</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On April 22, VirnetX Holding announced that it has established an advisory board comprised of four retired senior U.S. Air Force leaders. The company's stock fell around 28% over the past month. It <a href="https://www.benzinga.com/quote/VIVK">has a 52-week low</a> of $0.44.</li>
<li>RSI Value: 27.07</li>
<li>VIVK Price Action: Shares of Vivakor fell 0.7% to close at $1.43 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"> trend in Vivakor stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070512/image-150.png" alt="" class="wp-image-555846" style="width:657px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070512/image-150.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070512/image-150-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070512/image-150-768x702.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">Crown LNG Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>)</h3>
<ul>
<li>On Sept. 17, Crown LNG announced it received a Nasdaq notification regarding Nasdaq listing rule 5550(a)(2) for failing to meet its minimum bid requirements. The company's shares fell around 45% over the past month and has a 52-week<a href="https://www.benzinga.com/quote/GGR"> low of $0.26</a>.</li>
<li>RSI Value: 22.60</li>
<li>CGBS Price Action: Shares of Crown LNG Holdings fell 10.6% to close at $0.26 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">breakout in Crown LNG Holdings share</a>s. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="892" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070540/image-151.png" alt="" class="wp-image-555848" style="width:602px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070540/image-151.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070540/image-151-300x285.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070540/image-151-768x729.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Long Ideas

CGBS

VIVK

Top 3 Energy Stocks That Could Lead To Your Biggest Gains This Month

Stock Split

BBGI

Beasley Broadcast Has Approved A Reverse Stock Split At A Ratio Of 1-for-20

Guidance

Darden Restaurants Reiterated Full Year Financial Outlook For Fiscal 2025: Sees Net Earnings Per Share From Continuing Operations Of $9.40 To $9.60

Jackson will succeed Dave Rush, who has served as CEO since November 2022 and is retiring after 25 years of dedicated service to the Company. Rush will remain on the Builders FirstSource Board of Directors and continue as a special advisor to ensure a smooth transition.

Builders FirstSource Names CFO Peter Jackson As Its Next President & CEO And Member Of Its Board Of Directors, Effective November 6, 2024

Biotech

Health Care

ENSC

Ensysce Biosciences Has Submitted To FDA Its PF614-301 Protocol Of The Study To Evaluate The Efficacy And Safety Of PF614 For Moderate To Severe Pain After Abdominoplasty

Earnings

MoneyHero Q2 Sales $20.67M Up From $16.65M YoY

Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) reported quarterly earnings of $1.75 per share which missed the analyst consensus estimate of $1.83 by 4.37 percent. This is a 1.69 percent decrease over earnings of $1.78 per share from the same period last year. The company reported quarterly sales of $2.76 billion which missed the analyst consensus estimate of $2.80 billion by 1.54 percent. This is a 0.95 percent increase over sales of $2.73 billion the same period last year.

Earnings Misses

Darden Restaurants Q1 Adj $1.75 Misses $1.83 Estimate, Sales $2.76B Miss $2.80B Estimate

TNXP

Tonix Pharmaceuticals Secures US Patent Claiming Pharmaceutical Composition, Method Of Treating Migraine Via Intranasal Administration, And An Intranasal Delivery System For Tosymra. This Patent, Excluding Possible Patent Term Extensions, Is Expected To Expire In 2030.

VNDA

The FDA Declined To Approve Vanda's New Drug Application Of Tradipitant For The Treatment Of Symptoms In Gastroparesis, Providing Vanda With A Complete Response Letter

Business Outlook Operating Margin, Net Income and Diluted EPS
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">(Unaudited)</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">Figures may not foot due to rounding</td>
<td colspan="6">Annual Fiscal 2025 Guidance</td>
</tr>
<tr>
<td colspan="3">(In millions, except per share data)</td>
<td colspan="3">Low end of range</td>
<td colspan="3">High end of range</td>
</tr>
<tr>
<td colspan="3">Revenues</td>
<td>$</td>
<td>2,285&nbsp;</td>
<td>&nbsp;</td>
<td>$</td>
<td>2,305&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Operating income</td>
<td>$</td>
<td>765&nbsp;</td>
<td>&nbsp;</td>
<td>$</td>
<td>749&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Operating margin</td>
<td colspan="2">33.5&nbsp;</td>
<td>%</td>
<td colspan="2">32.5&nbsp;</td>
<td>%</td>
</tr>
<tr>
<td colspan="3">Intangible asset amortization</td>
<td colspan="2">80&nbsp;</td>
<td>&nbsp;</td>
<td colspan="2">81&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Adjusted operating income</td>
<td>$</td>
<td>845&nbsp;</td>
<td>&nbsp;</td>
<td>$</td>
<td>830&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Adjusted operating margin (a)</td>
<td colspan="2">37.0&nbsp;</td>
<td>%</td>
<td colspan="2">36.0&nbsp;</td>
<td>%</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">Net income</td>
<td>$</td>
<td>598&nbsp;</td>
<td>&nbsp;</td>
<td>$</td>
<td>577&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Intangible asset amortization</td>
<td colspan="2">66&nbsp;</td>
<td>&nbsp;</td>
<td colspan="2">66&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Discrete tax items</td>
<td colspan="2">(4)</td>
<td>&nbsp;</td>
<td colspan="2">(3)</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Adjusted net income</td>
<td>$</td>
<td>660&nbsp;</td>
<td>&nbsp;</td>
<td>$</td>
<td>640&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">Diluted earnings per common share</td>
<td>$</td>
<td>15.70&nbsp;</td>
<td>&nbsp;</td>
<td>$</td>
<td>15.10&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Intangible asset amortization</td>
<td colspan="2">1.73&nbsp;</td>
<td>&nbsp;</td>
<td colspan="2">1.73&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Discrete tax items</td>
<td colspan="2">(0.03)</td>
<td>&nbsp;</td>
<td colspan="2">(0.03)</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">Adjusted diluted earnings per common share</td>
<td>$</td>
<td>17.40&nbsp;</td>
<td>&nbsp;</td>
<td>$</td>
<td>16.80&nbsp;</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

FactSet Research Systems Expects FY25 Revenue Of $2.285B-$2.305B Vs $2.301B Est, Adj EPS Of $16.80-$17.40 Vs $17.36 Est

Knowles Updates Q3 Guidance To Reflect Anticipated Sale Of CMM Business; Now Sees Revenues From Cont Ops Of $139M - $143M, Adj EPS From Cont Ops Of $0.24 - $0.28

Knowles is updating its&nbsp;third quarter&nbsp;2024&nbsp;guidance&nbsp;to reflect the anticipated sale of the CMM business. Operating results for the CMM segment will be reported as discontinued operations beginning in the&nbsp;third quarter&nbsp;of 2024.

Knowles  Expects Q4 Revenue From Continuing Operations To Be $140M -$150M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest ones worth keeping an eye on this morning!



Moving stocks are new partnerships, asset sales, a $14 billion offer and more!



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>SINTX Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sint-stock-quote/">SINT</a>) stock is rocketing more than 45% <a href="https://www.nasdaq.com/press-release/sintx-subsidiary-technology-assessment-transfer-to-develop-3d-printing-and-cmcs-with">on a partnership with</a> the U.S. Army Combat Capabilities Development Command Army Research Laboratory.</li>



<li>Biodexa Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/bdrx-stock-quote/">BDRX</a>) shares are soaring over 34% without any clear news this morning.</li>



<li>Lytus Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyt-stock-quote/">LYT</a>) stock is surging more than 26% with heavy trading this morning.</li>



<li>Revelation Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/revb-stock-quote/">REVB</a>) shares are gaining over 23% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318020126&amp;type=PDF&amp;symbol=REVB&amp;cdn=f138abb7f94f8382dead44fb0a16b8e6&amp;companyName=Revelation+Biosciences+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-01-30">publishing an updated corporate presentation</a>.</li>



<li>Paramount Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/para-stock-quote/">PARA</a>) stock is increasing more than 16% on a <a href="https://www.bloomberg.com/news/articles/2024-01-31/byron-allen-makes-14-billion-offer-for-all-of-paramount-global">$14 billion offer for the company</a>.</li>



<li>Guardion Health Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ghsi-stock-quote/">GHSI</a>) shares are rising over 16% after <a href="https://www.globenewswire.com/news-release/2024/01/30/2820566/0/en/Guardion-Health-Sciences-Announces-Entry-into-Definitive-Agreement-to-Sell-its-Well-Known-Viactiv-Brand-and-Business-to-Doctor-s-Best-Inc.html">agreeing to sell one of its brands</a>.</li>



<li>Pop Culture (NASDAQ:<a href="https://investorplace.com/stock-quotes/cpop-stock-quote/">CPOP</a>) stock is climbing 15% on no apparent news today.</li>



<li>ECD Automotive Design (NASDAQ:<a href="https://investorplace.com/stock-quotes/ecda-stock-quote/">ECDA</a>) shares are getting a more than 14% boost this morning.</li>



<li>Yatsen (NYSE:<a href="https://investorplace.com/stock-quotes/ysg-stock-quote/">YSG</a>) stock is jumping over 13% on Wednesday morning.</li>



<li>Paramount Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/paraa-stock-quote/">PARAA</a>) shares are up more than 13% alongside PARA stock.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Remark (NASDAQ:<a href="https://investorplace.com/stock-quotes/mark-stock-quote/">MARK</a>) stock is crashing over 43% after a massive rally yesterday <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318020159&amp;type=PDF&amp;symbol=MARK&amp;cdn=17ad4850879ed581d2af8fcdda76bda7&amp;companyName=Remark+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-01-30">on a deal with Microsoft</a> (NASDAQ:<a href="https://investorplace.com/stock-quotes/msft-stock-quote/">MSFT</a>).</li>



<li>Nuvve (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvve-stock-quote/">NVVE</a>) shares are plummeting more than 39% on Wednesday.</li>



<li>Huize (NASDAQ:<a href="https://investorplace.com/stock-quotes/huiz-stock-quote/">HUIZ</a>) stock is diving over 32% this morning.</li>



<li>Synaptogenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/snpx-stock-quote/">SNPX</a>) shares are tumbling close to 22% with strong trading this morning.</li>



<li>SMX (Security Matters) (NASDAQ:<a href="https://investorplace.com/stock-quotes/smx-stock-quote/">SMX</a>) stock is taking a nearly 18% beating with a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318017337&amp;type=PDF&amp;symbol=SMX&amp;cdn=c11191857e8ba23d57636b641d35fe83&amp;companyName=SMX+%28Security+Matters%29+Public+Limited+Company&amp;formType=F-1&amp;formDescription=Registration+statement+for+securities+of+certain+foreign+private+issuers&amp;dateFiled=2024-01-30">proposed public offering</a>.</li>



<li>Innovative Eyewear (NASDAQ:<a href="https://investorplace.com/stock-quotes/lucy-stock-quote/">LUCY</a>) shares are sliding more than 17% without any news to mention.</li>



<li>American Superconductor (NASDAQ:<a href="https://investorplace.com/stock-quotes/amsc-stock-quote/">AMSC</a>) stock is dropping over 14% with a <a href="https://www.nasdaq.com/press-release/amsc-announces-proposed-public-offering-of-common-stock-2024-01-30">planned public offering</a>.</li>



<li>Oblong (NASDAQ:<a href="https://investorplace.com/stock-quotes/oblg-stock-quote/">OBLG</a>) shares are decreasing more than 12% this morning.</li>



<li>Pinstripes (NYSE:<a href="https://investorplace.com/stock-quotes/pnst-stock-quote/">PNST</a>) stock is slipping over 12% today.</li>



<li>GRIID Infrastructure (NASDAQ:<a href="https://investorplace.com/stock-quotes/grdi-stock-quote/">GRDI</a>) shares close out our pre-market stock movers down almost 11% <a href="https://finance.yahoo.com/news/griid-begin-trading-nasdaq-global-120000583.html">after its new listing</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-jan-31st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Thursday and we&rsquo;re starting the day with a breakdown of all the latest news traders need to know this morning!



Moving stocks this morning are earnings reports, an asset sale and more.



Let&rsquo;s jump into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Agile Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/agrx-stock-quote/">AGRX</a>) stock is rocketing more than 174% alongside heavy pre-market trading.</li>



<li>BuzzFeed (NASDAQ:<a href="https://investorplace.com/stock-quotes/bzfd-stock-quote/">BZFD</a>) shares are soaring over 85% after <a href="https://finance.yahoo.com/news/buzzfeed-inc-announces-sale-complex-210500093.html">announcing an asset sale</a>.</li>



<li>Elevai Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/elab-stock-quote/">ELAB</a>) stock is surging more than 39% with strong early morning trading.</li>



<li>GraniteShares 2x Long NVDA Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvdl-stock-quote/">NVDL</a>) shares are gaining over 28% after Nvidia (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>) <a href="https://www.cnbc.com/2024/02/22/ai-and-semiconductor-stocks-surge-after-nvidias-earnings-beat.html">posted a strong earnings beat</a>.</li>



<li>Eastside Distilling (NASDAQ:<a href="https://investorplace.com/stock-quotes/east-stock-quote/">EAST</a>) stock is heading more than 25% higher with heavy trading this morning.</li>



<li>Root (NASDAQ:<a href="https://investorplace.com/stock-quotes/root-stock-quote/">ROOT</a>) shares are rising over 23% with the release of its <a href="https://www.nasdaq.com/press-release/root-inc.-announces-2023-fourth-quarter-and-full-year-results-2024-02-21">latest earnings report</a>.</li>



<li>Beamr Imaging (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmr-stock-quote/">BMR</a>) stock is increasing more than 22% as it joins in on a stock rally led by Nvidia.</li>



<li>Remitly Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/rely-stock-quote/">RELY</a>) shares are jumping over 22% after reporting growth in its <a href="https://finance.yahoo.com/news/remitly-global-inc-rely-reports-213315264.html">most recent earnings report</a>.</li>



<li>DDC Enterprise (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ddc-stock-quote/">DDC</a>) stock is getting a more than 21% boost this morning.</li>



<li>Direxion Daily NVDA Bull 1.5X Shares (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvdu-stock-quote/">NVDU</a>) are up over 20% with the latest NVDA earnings news.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>iShares Core S&amp;P Mid-Cap ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/ijh-stock-quote/">IJH</a>) stock is crashing more than 79% on Thursday morning.</li>



<li>Draganfly (NASDAQ:<a href="https://investorplace.com/stock-quotes/dpro-stock-quote/">DPRO</a>) shares are plummeting over 51% after <a href="https://finance.yahoo.com/news/draganfly-announces-proposed-public-offering-210500823.html">announcing a proposed public offering</a>.</li>



<li>GraniteShares 2x Short NVDA Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvd-stock-quote/">NVD</a>) stock is diving more than 29% after the Nvidia earnings beat.</li>



<li>Bel Fuse (NASDAQ:<a href="https://investorplace.com/stock-quotes/belfb-stock-quote/">BELFB</a>) shares are tumbling over 21% <a href="https://www.nasdaq.com/press-release/bel-reports-fourth-quarter-and-full-year-2023-results-2024-02-21">alongside its latest earnings release</a>.</li>



<li>Synaptogenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/snpx-stock-quote/">SNPX</a>) stock is decreasing more than 20% this morning.</li>



<li>Greenbrook TMS (NASDAQ:<a href="https://investorplace.com/stock-quotes/gbnh-stock-quote/">GBNH</a>) shares are taking an over 18% beating <a href="https://investorplace.com/2024/02/why-is-greenbrook-tms-gbnh-stock-up-174-today/">after a rally yesterday</a>.</li>



<li>AXS 1.25X NVDA Bear Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvds-stock-quote/">NVDS</a>) stock is sliding more than 17% following NVDA&rsquo;s earnings results.</li>



<li>Momentus (NASDAQ:<a href="https://investorplace.com/stock-quotes/mnts-stock-quote/">MNTS</a>) shares are dropping over 17% this morning.</li>



<li>Lakeshore Acquisition II (NASDAQ:<a href="https://investorplace.com/stock-quotes/lbbb-stock-quote/">LBBB</a>) stock is dipping more than 16% today.</li>



<li>Visionary (NASDAQ:<a href="https://investorplace.com/stock-quotes/gv-stock-quote/">GV</a>) shares close out our pre-market stock movers down over 14%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/02/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-feb-22nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Synaptogenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/snpx-stock-quote/">SNPX</a>) just reported results for the first quarter of 2024.<ul><li>Synaptogenix reported earnings per share of -41 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/snpx-stock-earnings-synaptogenix-for-q1-of-2024/">SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024

An announcement from Synaptogenix (SNPX) is now available. Synaptogenix, Inc. has extended the term of Dr. Alan J. Tuchman, their CEO, through an a...

Synaptogenix CEO Dr. Tuchman's Tenure Extended Through 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Synaptogenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/snpx-stock-quote/">SNPX</a>) just reported results for the second quarter of 2024.<ul><li>Synaptogenix reported earnings per share of -$1.18.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/snpx-stock-earnings-synaptogenix-for-q2-of-2024/">SNPX Stock Earnings: Synaptogenix Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SNPX Stock Earnings: Synaptogenix Reported Results for Q2 2024

Synaptogenix announces $5M financing

AMSC

BDRX

CPOP

ECDA

GHSI

GRDI

HUIZ

LBBB

LUCY

MARK

MSFT

NVDL

NVDS

NVDU

NVVE

OBLG

PARA

PARAA

PNST

REVB

SINT

Press Releases

Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease

Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's

Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age-Related Diseases and Neurodegenerative Disorders

Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing

Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics

Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery

Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Offerings

Synaptogenix Announces $5.0 Million Financing

Ainos

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Anitra

Bone Biologics

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Chromocell Therapeutics Corporation Common Stock

Chromocell Therapeutics

GT Biopharma

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Oragenics

Onconetix

Oncternal Therapeutics, Inc. - Common Stock

Oncternal Therapeutics

Palisade Bio

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Sunshine Biopharma

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals

SILO Pharma

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings)

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Theriva Biologics

Trevena

Exicure

Maxim Group

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Synaptogenix

Synaptogenix (SNPX) Forecast

Synaptogenix (NASDAQ:SNPX) Stock, Quote.Headers.trade-ideas